or Try an Advanced Search...

    Technical Analysis for ARTV - Artiva Biotherapeutics, Inc.

    Grade Last Price % Change Price Change
    D 11.73 -1.43% -0.17
    ARTV closed down 1.43 percent on Thursday, September 19, 2024, on 2.49 times normal volume.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent N/A N/A Up
    Historical ARTV trend table...
    Date Alert Name Type % Chg
    Inside Day Range Contraction 0.00%
    Crossed Above 20 DMA Bullish -1.43%
    Pocket Pivot Bullish Swing Setup -1.43%
    20 DMA Resistance Bearish 7.12%
    Multiple of Ten Bullish Other 7.12%
    Gapped Up Strength 7.12%
    Oversold Stochastic Weakness 7.12%
    New 52 Week Closing Low Bearish 19.69%
    Stochastic Reached Oversold Weakness 19.69%
    Multiple of Ten Bearish Other 19.69%
    Older End-of-Day Signals for ARTV ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 3 hours ago
    Possible Inside Day about 3 hours ago
    Down 3% about 6 hours ago
    Down 2 % about 6 hours ago
    Down 1% about 6 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    ARTV Chart by TradingView
    Basic chart:

    Profile

    • Earnings date: Unknown
    Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Cancer Therapies For Cancer Hematologic Cancers Seagen

    Is ARTV a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 1 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Sep 10 Artiva Biotherapeutics to Participate in the 2024 Cantor Fitzgerald Global Healthcare Conference
    Aug 29 Artiva Biotherapeutics GAAP EPS of -$22.00
    Aug 29 Artiva Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
    Aug 11 Wall Street Breakfast: The Week Ahead
    Jul 19 Artiva Biotherapeutics surges on trading debut
    Jul 19 Artiva Biotherapeutics announces pricing of upsized $167M IPO
    Jul 18 Artiva Biotherapeutics Announces Pricing of Upsized $167.0 Million Initial Public Offering
    Jul 15 IPO Roundup: Ardent Health, TWFG, Artiva Biotherapeutics, and more
    See more ARTV news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 16.0
    52 Week Low 9.71
    Average Volume 115,059
    200-Day Moving Average 0.00
    50-Day Moving Average 0.00
    20-Day Moving Average 11.13
    10-Day Moving Average 11.24
    Average True Range 0.82
    RSI (14) 55.95
    ADX 17.63
    +DI 23.32
    -DI 22.58
    Chandelier Exit (Long, 3 ATRs) 9.87
    Chandelier Exit (Short, 3 ATRs) 12.16
    Upper Bollinger Bands 12.58
    Lower Bollinger Band 9.67
    Percent B (%b) 0.71
    BandWidth 26.13
    MACD Line -0.04
    MACD Signal Line -0.10
    MACD Histogram 0.0526
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 13.01
    Resistance 3 (R3) 12.99 12.54 12.79
    Resistance 2 (R2) 12.54 12.22 12.55 12.72
    Resistance 1 (R1) 12.14 12.02 11.92 12.16 12.65
    Pivot Point 11.69 11.69 11.58 11.70 11.69
    Support 1 (S1) 11.29 11.37 11.07 11.31 10.81
    Support 2 (S2) 10.84 11.17 10.85 10.74
    Support 3 (S3) 10.44 10.84 10.67
    Support 4 (S4) 10.46